Browse by Medical Category
Calendar of events
Learn about our fellowships and residency offerings, including the hematology/oncology fellowship program, our clinical training in hematology/medical oncology, and the Mass General Hospital Cancer Center residency program.
Massachusetts General Hospital, Dana-Farber Cancer Institute and other members of Partners Cancer Care offer a program in hematology/oncology that prepares academically oriented physicians to become leaders in clinical and laboratory investigation and clinical teaching.
The program offers training in only hematology or oncology, but it is anticipated that the vast majority of fellows will elect to train in both subspecialties as defined in the 36-month program by the American Board of Internal Medicine.The program involves an initial year of intensive clinical training, followed by two or more years of in-depth clinical and/or basic research training. There is also the opportunity for an additional six months of clinical experience.
During the first year of training, fellows divide their time between the Massachusetts General Hospital (MGH) and the Longwood campuses. The combined institutions have more than 1,400 beds, more than 100 of which are assigned to medical oncology and hematology, and nearly 40 of which are dedicated to bone marrow transplantation.
At each campus, ambulatory hematology and oncology experiences are organized around disease-specific programs.Fellows working in inpatient services provide care and consultative services in hematology and medical oncology to a varied population of patients, including bone marrow transplant patients.
During the clinical year, fellows acquire a panel of patients for whom they provide longitudinal, primary care in oncology and hematology under the direct supervision of a faculty member. Trainees also attend a wide variety of teaching conferences, including an orientation lecture series, weekly hematology/medical oncology grand rounds, and weekly new patient conferences at both the MGH and Longwood campuses. In addition, there are weekly disease-oriented teaching sessions sponsored by the relevant programs.
During the autumn of the first year of the fellowship, trainees begin exploring options for investigative efforts around their individual interests. At the beginning of the second year, fellows are expected to begin a period of detailed training and research, with the aim of assuming independent research programs in respected academic institutions. The time required to complete this task will depend on the past experiences of each fellow.
A variety of investigative opportunities, ranging from the most fundamental molecular biology to clinical trials and health outcome analyses, are available at MGH, Dana-Farber, Brigham and Women's Hospital, as well as in laboratories located at the MGH Cancer Center in Charlestown, the Harvard Medical School, Boston Children's Hospital, and the Massachusetts Institute of Technology.
Trainees who have completed their scientific training in this environment have had excellent experiences, and the program faculty views the successful training and academic placement of its clinical trainees as a fundamental responsibility.Application procedure
All applications for this program are now processed through the Electronic Residency Application Service (ERAS). Please note that this program is listed under Brigham and Women's Hospital.
The deadline for applications is August 31.
The Massachusetts General Hospital offers specialized residencies in each of our multidisciplinary care centers and clinical departments. See information on residencies here.
Back to Top